Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease

Table 1

Patient demographics and treatments (104 cases).

	Number of patients (𝑛=104)
Sex
Male	71 (68%)
Female	33 (32%)
Type of disease
Ileitis	28 (27%)
Ileocolitis	67 (64%)
Colitis	9 (9%)
The age of onset
Median	22
Range	10–66
The history of corticosteroid use until the first operation
(+)	33 (32%)
(−)	71 (68%)
The history of immunomodulator use until the first operation
(+)	37 (36%)
(−)	67 (64%)
The history of infliximab use until the first operation
(+)	39 (38%)
(−)	65 (62%)
The history of enteral nutrition
(+)	96 (92%)
(−)	8 (8%)
Bowel surgery
(+)	69 (66%)
(−)	35 (34%)